» GeoVax Labs to launch phase II <b>trials</b> of HIV vaccine candidate
The Atlanta-based biotechnology firm GeoVax Labs plans to launch Phase II clinical trials of its experimental HIV vaccine this summer, company officials recently announced, the Atlanta…